Your browser doesn't support javascript.
loading
BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics.
Thomas, Dirk; Thelen, Kirstin; Kraff, Stefanie; Schwers, Stephan; Schiffer, Sonja; Unger, Sigrun; Yassen, Ashraf; Boxnick, Stefanie.
Afiliación
  • Thomas D; Experimental Medicine CV/HEM, Research & Development Bayer AG Wuppertal Germany.
  • Thelen K; Clinical PK CV, Research & Development Bayer AG Wuppertal Germany.
  • Kraff S; Clinical PK CV, Research & Development Bayer AG Wuppertal Germany.
  • Schwers S; Experimental Medicine CV/HEM, Research & Development Bayer AG Wuppertal Germany.
  • Schiffer S; Experimental Medicine CV/HEM, Research & Development Bayer AG Wuppertal Germany.
  • Unger S; Research & Clinical Sciences Statistics, Research & Development Bayer AG Wuppertal Germany.
  • Yassen A; Clinical Pharmacometrics, Research & Development Bayer AG Wuppertal Germany.
  • Boxnick S; CRS Clinical Research Services Wuppertal GmbH Wuppertal Germany.
Res Pract Thromb Haemost ; 3(2): 242-253, 2019 Apr.
Article en En | MEDLINE | ID: mdl-31011708
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Res Pract Thromb Haemost Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Res Pract Thromb Haemost Año: 2019 Tipo del documento: Article